Pharma Pricing & Market Access Europe 2014
Organization: Health Network Communications
Venue: Business Design Centre
|Event Date/Time: Feb 24, 2014 / 9:00 am - (GMT)||End Date/Time: Feb 26, 2014 / 5:00 pm - (GMT)|
The 8th Annual Pharma Pricing and Market Access Outlook World Europe is the world’s largest gathering of pharmaceutical pricing, market access and reimbursement professionals regularly attracting a high attendance.
It is a two day strategic conference addressing the critical policy issues in developing the optimum pricing strategy for pharmaceutical products.
- How the policy challenges in market access will effect you
- How to produce an optimum pricing strategy for pharma products
- How HTA practice effects the markets they are working in
- How innovative pricing and risk sharing models between industry and payers have changed
Professor David Haslam , Chairman, NICE
Adam Pilch , Head of Market Access, TEVA
Thomas Mueller , Head of Pharmaceuticals, G-BA Germany
Professor Lise Rochaix , Member of the Board, HAS, France
Saira Jan, Director, Clinical Pharmacy Program Management, BCBS
Dr Paolo Daniele Siviero, Head of Economic Strategy and Pharmaceutical Policy, AIFA, Italy